drugset / Trial / NCT01557660
Inhaled Treprostinil for PAH: Open-label Extension
NaSingle-groupOpen-labelTreatment
Summary
Open-label extension of RIN-PH-302.
Timeline
- Start
- 2012-06
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | 0.6 mg/ml | Inhaled |